Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Nov;64(5):933–937. doi: 10.1038/bjc.1991.429

Involved field radiotherapy or chemotherapy in the management of stage I nodal intermediate grade non-Hodgkin's lymphoma.

G M Jeffery 1, G M Mead 1, J M Whitehouse 1, R D Ryall 1
PMCID: PMC1977466  PMID: 1931619

Abstract

Early stage intermediate grade non-Hodgkin's lymphoma (NHL) is frequently treated with chemotherapy alone or in conjunction with radiotherapy. We have managed clinical Stage I nodal, intermediate grade NHL with involved field radiotherapy alone for non-bulky (less than 5 cm post-surgery) disease or combination chemotherapy alone for more bulky disease. Forty-three patients were treated between 1978 and 1989. Of the 30 patients with non-bulky disease treated with radiotherapy, 29 (97%) achieved complete remission (CR). Thirteen (42%) patients relapsed after radiotherapy and ten of these achieved a further CR (durable in eight) following salvage chemotherapy. Eleven patients with bulky disease received combination chemotherapy with nine (82%) attaining CR (durable in eight). Two patients with bulky disease received radiotherapy-both achieved CR, but have relapsed and died of lymphoma. Overall actuarial 5 year survival for the total group is 77% with a median follow-up of 30 months (range 3-119 months). The 5 year actuarial survival for the 30 patients with non-bulky disease treated with radiotherapy is 86% at a median follow-up of 39 months (range 8-119 months). The 4 year actuarial survival of the 11 patients treated with chemotherapy is 60% with a median follow-up of 25 months (range 3-55 months). We conclude that involved field radiotherapy alone is efficacious for clinical stage I patients with non-bulky nodal intermediate grade NHL and that patients relapsing after radiotherapy are adequately salvaged by chemotherapy. Patients with bulky disease have an inferior survival and should receive combination chemotherapy.

Full text

PDF
933

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armitage J. O., Wen B. C. Chemotherapy in patients who fail radiotherapy for diffuse aggressive non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 1987 Sep;13(9):1351–1354. doi: 10.1016/0360-3016(87)90228-8. [DOI] [PubMed] [Google Scholar]
  2. Bitran J. D., Kinzie J., Sweet D. L., Variakojis D., Griem M. L., Golomb H. M., Miller J. B., Oetzel N., Ultmann J. E. Survival of patients with localized histiocytic lymphoma. Cancer. 1977 Jan;39(1):342–346. doi: 10.1002/1097-0142(197701)39:1<342::aid-cncr2820390151>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  3. Cabanillas F. Chemotherapy as definitive treatment of stage I-II large cell and diffuse mixed lymphomas. Hematol Oncol. 1985 Jan-Mar;3(1):25–31. doi: 10.1002/hon.2900030104. [DOI] [PubMed] [Google Scholar]
  4. Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860–1861. [PubMed] [Google Scholar]
  5. Carde P., Burgers J. M., van Glabbeke M., Hayat M., Cosset J. M., Somers R., Sizoo W., Qasim M. M., Lefur R., Abbatucci J. S. Combined radiotherapy-chemotherapy for early stages non-Hodgkin's lymphoma: the 1975-1980 EORTC controlled lymphoma trial. Radiother Oncol. 1984 Dec;2(4):301–312. doi: 10.1016/s0167-8140(84)80072-9. [DOI] [PubMed] [Google Scholar]
  6. Chen M. G., Prosnitz L. R., Gonzalez-Serva A., Fischer D. B. Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma. Cancer. 1979 Apr;43(4):1245–1254. doi: 10.1002/1097-0142(197904)43:4<1245::aid-cncr2820430412>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  7. Connors J. M., Klimo P., Fairey R. N., Voss N. Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma. Ann Intern Med. 1987 Jul;107(1):25–30. doi: 10.7326/0003-4819-107-1-25. [DOI] [PubMed] [Google Scholar]
  8. DeVita V. T., Jr, Canellos G. P., Chabner B., Schein P., Hubbard S. P., Young R. C. Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet. 1975 Feb 1;1(7901):248–250. doi: 10.1016/s0140-6736(75)91142-3. [DOI] [PubMed] [Google Scholar]
  9. Doll D. C., Weiss R. B. Malignant lymphoma of the testis. Am J Med. 1986 Sep;81(3):515–524. doi: 10.1016/0002-9343(86)90308-6. [DOI] [PubMed] [Google Scholar]
  10. Duncan P. R., Checa F., Gowing N. F., McElwain T. J., Peckham M. J. Extranodal non-Hodgkin's lymphoma presenting in the testicle: a clinical and pathologic study of 24 cases. Cancer. 1980 Apr 1;45(7):1578–1584. doi: 10.1002/1097-0142(19800401)45:7<1578::aid-cncr2820450711>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  11. Freeman C., Berg J. W., Cutler S. J. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972 Jan;29(1):252–260. doi: 10.1002/1097-0142(197201)29:1<252::aid-cncr2820290138>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  12. Goffinet D. R., Warnke R., Dunnick N. R., Castellino R., Glatstein E., Nelsen T. S., Dorfman R. F., Rosenberg S. A., Kaplan H. S. Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas. Cancer Treat Rep. 1977 Sep;61(6):981–992. [PubMed] [Google Scholar]
  13. Gospodarowicz M. K., Sutcliffe S. B., Brown T. C., Chua T., Bush R. S. Patterns of disease in localized extranodal lymphomas. J Clin Oncol. 1987 Jun;5(6):875–880. doi: 10.1200/JCO.1987.5.6.875. [DOI] [PubMed] [Google Scholar]
  14. Hagberg H., Pettersson U., Glimelius B., Sundström C. Prognostic factors in non-Hodgkin lymphoma stage I treated with radiotherapy. Acta Oncol. 1989;28(1):45–50. doi: 10.3109/02841868909111180. [DOI] [PubMed] [Google Scholar]
  15. Hallahan D. E., Farah R., Vokes E. E., Bitran J. D., Ultmann J. E., Golomb H. M., Weichselbaum R. R. The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone. Int J Radiat Oncol Biol Phys. 1989 Oct;17(4):767–771. doi: 10.1016/0360-3016(89)90064-3. [DOI] [PubMed] [Google Scholar]
  16. Hoppe R. T. The role of radiation therapy in the management of the non-Hodgkin's lymphomas. Cancer. 1985 May 1;55(9 Suppl):2176–2183. doi: 10.1002/1097-0142(19850501)55:9+<2176::aid-cncr2820551421>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  17. Horwich A., Catton C. N., Quigley M., Easton D., Brada M. The management of early-stage aggressive non-Hodgkin's lymphoma. Hematol Oncol. 1988 Oct-Dec;6(4):291–298. doi: 10.1002/hon.2900060404. [DOI] [PubMed] [Google Scholar]
  18. Jacobson J. O., Aisenberg A. C., Lamarre L., Willett C. G., Linggood R. M., Miketic L. M., Harris N. L. Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy. Cancer. 1988 Nov 1;62(9):1893–1898. doi: 10.1002/1097-0142(19881101)62:9<1893::aid-cncr2820620904>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  19. Jones S. E., Miller T. P., Connors J. M. Long-term follow-up and analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy. J Clin Oncol. 1989 Sep;7(9):1186–1191. doi: 10.1200/JCO.1989.7.9.1186. [DOI] [PubMed] [Google Scholar]
  20. Kaminski M. S., Coleman C. N., Colby T. V., Cox R. S., Rosenberg S. A. Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapy. Ann Intern Med. 1986 Jun;104(6):747–756. doi: 10.7326/0003-4819-104-6-747. [DOI] [PubMed] [Google Scholar]
  21. Kantarjian H. M., McLaughlin P., Fuller L. M., Dixon D. O., Osborne B. M., Cabanillas F. F. Follicular large cell lymphoma: analysis and prognostic factors in 62 patients. J Clin Oncol. 1984 Jul;2(7):811–819. doi: 10.1200/JCO.1984.2.7.811. [DOI] [PubMed] [Google Scholar]
  22. Lester J. N., Fuller L. M., Conrad F. G., Sullivan J. A., Velasquez W. S., Butler J. J., Shullenberger C. C. The roles of staging laparotomy, chemotherapy, and radiotherapy in the management of localized diffuse large cell lymphoma: a study of 75 patients. Cancer. 1982 May 1;49(9):1746–1753. doi: 10.1002/1097-0142(19820501)49:9<1746::aid-cncr2820490903>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  23. Levitt S. H., Lee C. K., Bloomfield C. D., Frizzera G. The role of radiation therapy in the treatment of early stage large cell lymphoma. Hematol Oncol. 1985 Jan-Mar;3(1):33–37. doi: 10.1002/hon.2900030105. [DOI] [PubMed] [Google Scholar]
  24. Littman P., Wang C. C. Reticulum cell sarcoma of the brain. A review of the literature and a study of 19 cases. Cancer. 1975 May;35(5):1412–1420. doi: 10.1002/1097-0142(197505)35:5<1412::aid-cncr2820350526>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  25. Longo D. L., Glatstein E., Duffey P. L., Ihde D. C., Hubbard S. M., Fisher R. I., Jaffe E. S., Gilliom M., Young R. C., DeVita V. T., Jr Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy. J Clin Oncol. 1989 Sep;7(9):1295–1302. doi: 10.1200/JCO.1989.7.9.1295. [DOI] [PubMed] [Google Scholar]
  26. Mackintosh J. F., Cowan R. A., Jones M., Harris M., Deakin D. P., Crowther D. Prognostic factors in stage I and II high and intermediate grade non-Hodgkin's lymphoma. Eur J Cancer Clin Oncol. 1988 Oct;24(10):1617–1622. doi: 10.1016/0277-5379(88)90054-5. [DOI] [PubMed] [Google Scholar]
  27. Martenson J. A., Jr, Buskirk S. J., Ilstrup D. M., Banks P. M., Evans R. G., Colgan J. P., Earle J. D. Patterns of failure in primary testicular non-Hodgkin's lymphoma. J Clin Oncol. 1988 Feb;6(2):297–302. doi: 10.1200/JCO.1988.6.2.297. [DOI] [PubMed] [Google Scholar]
  28. Mauch P., Leonard R., Skarin A., Rosenthal D., Come S., Chaffey J., Hellman S., Canellos G. Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I-II non-Hodgkin's lymphomas. J Clin Oncol. 1985 Oct;3(10):1301–1308. doi: 10.1200/JCO.1985.3.10.1301. [DOI] [PubMed] [Google Scholar]
  29. Mead G. M., Whitehouse J. M., Thompson J., Sweetenham J. W., Williams C. J., Wright D. H. Clinical features and management of malignant histiocytosis of the intestine. Cancer. 1987 Dec 1;60(11):2791–2796. doi: 10.1002/1097-0142(19871201)60:11<2791::aid-cncr2820601132>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  30. Mill W. B., Lee F. A., Franssila K. O. Radiation therapy treatment of stage I and II extranodal non-Hodgkin's lymphoma of the head and neck. Cancer. 1980 Feb 15;45(4):653–661. doi: 10.1002/1097-0142(19800215)45:4<653::aid-cncr2820450406>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  31. Miller T. P., Jones S. E. Initial chemotherapy for clinically localized lymphomas of unfavorable histology. Blood. 1983 Aug;62(2):413–418. [PubMed] [Google Scholar]
  32. Monfardini S., Banfi A., Bonadonna G., Rilke F., Milani F., Valagussa P., Lattuada A. Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 1980 Feb;6(2):125–134. doi: 10.1016/0360-3016(80)90027-9. [DOI] [PubMed] [Google Scholar]
  33. Peckham M. J., Guay J. P., Hamlin I. M., Lukes R. J. Survival in localized nodal and extranodal non-Hodgkin's lymphomata. Br J Cancer Suppl. 1975 Mar;2:413–424. [PMC free article] [PubMed] [Google Scholar]
  34. Pollack I. F., Lunsford L. D., Flickinger J. C., Dameshek H. L. Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer. 1989 Mar 1;63(5):939–947. doi: 10.1002/1097-0142(19890301)63:5<939::aid-cncr2820630526>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  35. Prestidge B. R., Horning S. J., Hoppe R. T. Combined modality therapy for stage I-II large cell lymphoma. Int J Radiat Oncol Biol Phys. 1988 Sep;15(3):633–639. doi: 10.1016/0360-3016(88)90305-7. [DOI] [PubMed] [Google Scholar]
  36. Reddy S., Saxena V. S., Pellettiere E. V., Hendrickson F. R. Stage I and II non-Hodgkin's lymphomas: long-term results of radiation therapy. Int J Radiat Oncol Biol Phys. 1989 Mar;16(3):687–692. doi: 10.1016/0360-3016(89)90486-0. [DOI] [PubMed] [Google Scholar]
  37. Rudders R. A., Ross M. E., DeLellis R. A. Primary extranodal lymphoma: response to treatment and factors influencing prognosis. Cancer. 1978 Aug;42(2):406–416. doi: 10.1002/1097-0142(197808)42:2<406::aid-cncr2820420205>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  38. Shigematsu N., Kondo M., Mikata A. Prognostic factors of stage I and II non-Hodgkin's lymphomas of the head and neck: the value of the working formulation and need for chemotherapy. Int J Radiat Oncol Biol Phys. 1988 Nov;15(5):1111–1118. doi: 10.1016/0360-3016(88)90192-7. [DOI] [PubMed] [Google Scholar]
  39. Sweetenham J. W., Mead G. M., Wright D. H., McKendrick J. J., Jones D. H., Williams C. J., Whitehouse J. M. Involvement of the ileocaecal region by non-Hodgkin's lymphoma in adults: clinical features and results of treatment. Br J Cancer. 1989 Sep;60(3):366–369. doi: 10.1038/bjc.1989.286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Taylor R. E., Allan S. G., McIntyre M. A., Kerr G. R., Taylor A. J., Ritchie G. L., Leonard R. C. Influence of therapy on local control and survival in stage I and II intermediate and high grade non-Hodgkin's lymphoma. Eur J Cancer Clin Oncol. 1988 Nov;24(11):1771–1777. doi: 10.1016/0277-5379(88)90080-6. [DOI] [PubMed] [Google Scholar]
  41. Todeschini G., Ambrosetti A., Meneghini V., Pizzolo G., Menestrina F., Chilosi M., Benedetti F., Veneri D., Cetto G. L., Perona G. Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients. J Clin Oncol. 1990 May;8(5):804–808. doi: 10.1200/JCO.1990.8.5.804. [DOI] [PubMed] [Google Scholar]
  42. Vokes E. E., Ultmann J. E., Golomb H. M., Gaynor E. R., Ferguson D. J., Griem M. L., Oleske D. Long-term survival of patients with localized diffuse histiocytic lymphoma. J Clin Oncol. 1985 Oct;3(10):1309–1317. doi: 10.1200/JCO.1985.3.10.1309. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES